MICHELLE DUFRENE: Open Payments
NPI 1174273627 · RACELAND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,600 in 77 payments from 17 companies in 2025. Trend: 2023 $1,079 · 2024 $965 · 2025 $1,600
Food & beverage: $1,600
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $377 |
| ABBVIE INC. | 13 | $223 |
| Kowa Pharmaceuticals America, Inc. | 5 | $165 |
| Lilly USA, LLC | 9 | $150 |
| Novo Nordisk Inc | 11 | $147 |
| COLOPLAST CORP | 1 | $111 |
| PFIZER INC. | 5 | $97 |
| GlaxoSmithKline, LLC. | 5 | $91 |
| Vanda Pharmaceuticals Inc. | 2 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
Products named: BREZTRI, ZORYVE, AIRSUPRA, MOUNJARO, Altis, PREVNAR 20, Ozempic, SHINGRIX.
Industry payments across LA — which companies pay providers there.
